Børsen
Efficiency and cost savings are on the agenda for Novo Nordisk’s new CEO, Mike Doustdar, but success requires him to halt the imitations in the USA.
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?